DE MURO, Pierina
 Distribuzione geografica
Continente #
NA - Nord America 4.365
AS - Asia 2.391
EU - Europa 1.576
SA - Sud America 1.301
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 44
OC - Oceania 7
Totale 9.770
Nazione #
US - Stati Uniti d'America 4.237
BR - Brasile 1.157
CN - Cina 851
SG - Singapore 850
UA - Ucraina 526
IT - Italia 324
HK - Hong Kong 230
DE - Germania 193
FR - Francia 150
VN - Vietnam 148
SE - Svezia 100
FI - Finlandia 87
GB - Regno Unito 87
CA - Canada 61
TR - Turchia 60
AR - Argentina 52
BD - Bangladesh 31
IQ - Iraq 31
ZA - Sudafrica 30
IN - India 26
MX - Messico 26
BE - Belgio 24
PK - Pakistan 24
VE - Venezuela 24
EC - Ecuador 22
KR - Corea 20
RU - Federazione Russa 20
UZ - Uzbekistan 18
MA - Marocco 17
JP - Giappone 16
PL - Polonia 15
CL - Cile 12
ID - Indonesia 12
CO - Colombia 11
ES - Italia 10
IL - Israele 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
CR - Costa Rica 8
DZ - Algeria 8
EU - Europa 8
GT - Guatemala 8
PE - Perù 8
PY - Paraguay 8
JO - Giordania 7
NP - Nepal 7
AU - Australia 6
NL - Olanda 6
PH - Filippine 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
EG - Egitto 5
LB - Libano 5
OM - Oman 5
AT - Austria 4
GR - Grecia 4
JM - Giamaica 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
GE - Georgia 3
LT - Lituania 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BS - Bahamas 2
CG - Congo 2
CH - Svizzera 2
CI - Costa d'Avorio 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
NI - Nicaragua 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
GY - Guiana 1
IE - Irlanda 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MF - Saint Martin 1
ML - Mali 1
Totale 9.724
Città #
Dallas 974
Singapore 483
Chandler 435
Jacksonville 316
San Jose 296
Ashburn 247
Hong Kong 229
Council Bluffs 162
Princeton 158
Beijing 150
Nanjing 147
Dearborn 104
Santa Clara 95
Columbus 93
São Paulo 88
New York 87
Ann Arbor 83
Wilmington 72
Lauterbourg 70
Nanchang 65
Sassari 61
Ho Chi Minh City 54
Los Angeles 48
Shanghai 45
Boardman 44
Milan 44
Shenyang 43
Hebei 39
Rio de Janeiro 39
Woodbridge 32
Belo Horizonte 30
Changsha 30
Tianjin 30
Hanoi 28
Ningbo 26
Izmir 25
Brussels 24
Campinas 23
Mountain View 22
Curitiba 21
Hangzhou 21
Johannesburg 21
Buffalo 20
Seoul 20
Jinan 19
Orem 19
Zhengzhou 18
Jiaxing 17
Tashkent 17
Toronto 17
Miano 15
Tokyo 15
Baghdad 14
Brasília 14
Kunming 14
San Francisco 14
Warsaw 14
Andover 13
Atlanta 13
Norwalk 13
Brooklyn 12
Goiânia 12
Catania 11
London 11
Montreal 11
Phoenix 11
Guangzhou 10
Guarulhos 10
Haiphong 10
Porto Alegre 10
Ribeirão Preto 10
Rome 10
Sorocaba 10
The Dalles 10
Betim 9
Boston 9
Cagliari 9
Casablanca 9
Helsinki 9
Caxias do Sul 8
Chennai 8
Da Nang 8
Denver 8
Florence 8
Manaus 8
Manchester 8
Nairobi 8
Quito 8
Stockholm 8
São José dos Campos 8
Campo Grande 7
Fortaleza 7
Frankfurt am Main 7
Osasco 7
Recife 7
Santo André 7
Villiers-sur-marne 7
Americana 6
Amman 6
Auburn Hills 6
Totale 5.738
Nome #
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 221
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 193
Apolipoprotein Profiles in Atherosclerotic Disease 190
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 186
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 172
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 166
A longitudinal evaluation of urinary glycosaminoglycan excretion in normoalbuminuric type 1 diabetic patients 165
Apolipoprotein Profiles in Atherosclerotic Disease 163
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 154
Buoyant density of Lp(a) subclasses in hypercholesterolemia 150
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 150
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 149
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 147
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 146
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 145
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 144
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 144
Quali-quantitative analysis of urinary glycosaminoglycans for monitoring glomerular inflammatory activity 143
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 142
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 140
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 140
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 140
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 137
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 136
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 134
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 132
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 130
Urinary glycosaminoglycan composition in chronic glomerulonephritis 130
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 129
Sulphated polysaccharide content and localization in some marine sponge species. 129
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 127
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 124
Blood and urine glycosaminoglycan variations during different hypocholesterolemic therapies in type 2 diabetic patients 123
Diversità molecolare negli invertebrati marini: screening dei glicosaminoglicani in spugne del Mediterraneo occidentale 123
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 121
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 120
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 119
Urine bikunin as a marker of renal impairment in Fabry's disease 119
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 119
DNA polymorphisms in North Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with betao-thalassemia. 119
Hb G-Philadelphia, or [alpha68(E17)AsnLys], in North Sardinia: detection by isoelectric focusing and HPLC of tryptic peptides 118
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 118
Glycosamynoglycan diversity in sponge extracellular matrix 116
GAG and protein composition of GAG-protein complexes from normal human plasma 113
Atherosclerotic modifications of human proteoglycans 112
Role of the small proteoglycan bikunin in human reproduction 112
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 111
Haematological and biosynthetic features of beta°-thalassemia with an associated alpha-thalassemia heterozygosity in Sardinia 111
Plasma GAG-protein complexes modify chemical and physical properties of human LDL 110
Preliminary investigations of LDL interactions with proteoglycans extracted from human aortic walls with different atherosclerotic lesions 110
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 109
Ruolo dei proteoglicani nella medicina della riproduzione 109
Urinary transaforming growth factor beta 1 in various types of nephropathy 108
Urinary transforming growth factor-beta 1 in various types of nephropathy 108
Evidences that atherosclerotic lesion involves modifications of arterial wall proteoglycans, affecting their interactions with LDL 108
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 107
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 107
Iloprost therapy acutely decreases oxidative stress in patients affected by systemic sclerosis 105
Urinary excretion of GAGs during hypocholesterolemic therapy 105
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 102
Urinary glycosaminoglycansin patients with systemic lupus erytematosus 100
The gamma globin chain heterogeneity of the Sardinian newborn baby 99
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 99
Modification of low density lipoprotein induced by the interaction with standard GAGs 99
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 98
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 97
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 96
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 94
Proteoglicani e diabete gestazionale: dati preliminari 94
Hematological and biosynthetic features of betao-thalassemia with an associated beta-thalassemia heterozygosity in Sardinia. 89
Investigations on PGs extracted from human aorta of different age and with different atherosclerotic lesions 88
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 88
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 88
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 86
Glycosaminoglycans and fabry’s disease 86
Human LDL binding to plasma high charge glycosaminoglycan-protein complexes 84
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 84
Glycosaminoglycan diversity in sponge extracellular matrix 82
Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes 80
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 79
Totale 9.770
Categoria #
all - tutte 40.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022331 0 0 0 11 6 2 24 26 46 25 39 152
2022/2023802 84 54 14 149 82 141 0 93 130 9 28 18
2023/2024227 45 19 7 4 48 50 1 11 0 1 23 18
2024/20252.307 18 17 128 30 110 48 192 368 827 403 108 58
2025/20262.903 119 774 351 376 264 204 356 98 150 135 56 20
2026/20271.053 65 276 319 393 0 0 0 0 0 0 0 0
Totale 9.770